PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ADCT vs. GERN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


ADCTGERN
YTD Return183.73%93.36%
1Y Return147.89%64.52%
3Y Return (Ann)-42.36%41.24%
Sharpe Ratio1.120.53
Daily Std Dev125.21%112.10%
Max Drawdown-99.08%-98.65%
Current Drawdown-90.77%-93.81%

Fundamentals


ADCTGERN
Market Cap$358.18M$2.23B
EPS-$2.94-$0.32
Revenue (TTM)$69.56M$237.00K
Gross Profit (TTM)$35.10M-$93.67M
EBITDA (TTM)-$164.80M-$193.50M

Correlation

-0.50.00.51.00.3

The correlation between ADCT and GERN is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

ADCT vs. GERN - Performance Comparison

In the year-to-date period, ADCT achieves a 183.73% return, which is significantly higher than GERN's 93.36% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%100.00%December2024FebruaryMarchAprilMay
-84.11%
133.14%
ADCT
GERN

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


ADC Therapeutics SA

Geron Corporation

Risk-Adjusted Performance

ADCT vs. GERN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ADC Therapeutics SA (ADCT) and Geron Corporation (GERN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ADCT
Sharpe ratio
The chart of Sharpe ratio for ADCT, currently valued at 1.12, compared to the broader market-2.00-1.000.001.002.003.004.001.12
Sortino ratio
The chart of Sortino ratio for ADCT, currently valued at 2.33, compared to the broader market-4.00-2.000.002.004.006.002.33
Omega ratio
The chart of Omega ratio for ADCT, currently valued at 1.28, compared to the broader market0.501.001.501.28
Calmar ratio
The chart of Calmar ratio for ADCT, currently valued at 1.42, compared to the broader market0.002.004.006.001.42
Martin ratio
The chart of Martin ratio for ADCT, currently valued at 3.22, compared to the broader market-10.000.0010.0020.0030.003.22
GERN
Sharpe ratio
The chart of Sharpe ratio for GERN, currently valued at 0.53, compared to the broader market-2.00-1.000.001.002.003.004.000.53
Sortino ratio
The chart of Sortino ratio for GERN, currently valued at 2.09, compared to the broader market-4.00-2.000.002.004.006.002.09
Omega ratio
The chart of Omega ratio for GERN, currently valued at 1.25, compared to the broader market0.501.001.501.25
Calmar ratio
The chart of Calmar ratio for GERN, currently valued at 1.12, compared to the broader market0.002.004.006.001.12
Martin ratio
The chart of Martin ratio for GERN, currently valued at 1.71, compared to the broader market-10.000.0010.0020.0030.001.71

ADCT vs. GERN - Sharpe Ratio Comparison

The current ADCT Sharpe Ratio is 1.12, which is higher than the GERN Sharpe Ratio of 0.53. The chart below compares the 12-month rolling Sharpe Ratio of ADCT and GERN.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00December2024FebruaryMarchAprilMay
1.12
0.53
ADCT
GERN

Dividends

ADCT vs. GERN - Dividend Comparison

Neither ADCT nor GERN has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ADCT vs. GERN - Drawdown Comparison

The maximum ADCT drawdown since its inception was -99.08%, roughly equal to the maximum GERN drawdown of -98.65%. Use the drawdown chart below to compare losses from any high point for ADCT and GERN. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2024FebruaryMarchAprilMay
-90.77%
-1.45%
ADCT
GERN

Volatility

ADCT vs. GERN - Volatility Comparison

ADC Therapeutics SA (ADCT) has a higher volatility of 22.41% compared to Geron Corporation (GERN) at 19.20%. This indicates that ADCT's price experiences larger fluctuations and is considered to be riskier than GERN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%60.00%70.00%December2024FebruaryMarchAprilMay
22.41%
19.20%
ADCT
GERN

Financials

ADCT vs. GERN - Financials Comparison

This section allows you to compare key financial metrics between ADC Therapeutics SA and Geron Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items